Product Details

Invokana

Canagliflozin
300 mg
Tablet


DIN/PIN/NPN

02425491

Manufacturer

Janssen Inc.

Formulary Listing Date

2015-07-29  

Unit Price

3.0060

Amount MOH Pays

3.0060

Coverage Status

General Benefit Chronic-Use Medication Insulin or Oral Hypoglycemic Product

ODB Formulary Therapeutic Classification

Therapeutic Note

Canagliflozin 300 mg Tablet: Treatment of Type 2 diabetes in patients on maximally tolerated doses of metformin who have: . Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea; OR . Inadequate glycemic control (HbA1c greater than 0.07) and on maximal doses of sulfonylurea and for whom insulin is not an option.

ATC Code

A10BK02

Interchangeable Products

NO  

LU Clinical Criteria

NO  

Requirements

NA

EAP Criteria

  NO

Product Monograph

View Monograph